Preparation and in Vivo evaluation of a dry powder for inhalation of capreomycin

被引:78
作者
Fiegel, Jennifer [1 ]
Garcia-Contreras, Lucila [2 ]
Thomas, Matthew [1 ]
VerBerkmoes, Jarod [1 ]
Elbert, Katharina [1 ]
Hickey, Anthony [2 ]
Edwards, David [1 ]
机构
[1] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA
[2] Univ N Carolina, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA
关键词
aerosols; antibiotics; insufflation; pulmonary drug delivery; tuberculosis;
D O I
10.1007/s11095-007-9381-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To develop an aerosol system for efficient local lung delivery of a tuberculostatic drug. Methods. The antibiotic, capreomycin sulfate, was spray dried to form a dry powder aerosol. The chemical content and physical properties of resulting particles were assessed under various storage conditions. Plasma concentrations of capreomycin after insufflation into guinea pigs were evaluated at three doses, and compared to IV and IM administration of a capreomycin solution. Results. Dry powder aerosols containing capreomycin were formulated to enable efficient delivery of large drug masses to the lungs of guinea pigs. Aerosols loaded with 73% CS were shown to possess good aerosolization properties and physical-chemical stability for up to 3 months at room temperature. Upon insufflation into guinea pigs, the amount of CS reaching the bloodstream was significantly lower compared to IV or IM administration, but resulted in a significantly longer drug half-life. Conclusions. The results indicate that large doses of capreomycin in dry powder form can be efficiently delivered to the lungs of guinea pigs, which may result in high local drug exposure but significantly reduced systemic exposure as suggested by plasma concentrations in the present studies. These systems have considerable potential to provide more effective therapy for MDR-TB.
引用
收藏
页码:805 / 811
页数:7
相关论文
共 26 条
[1]   Aerosolization properties, surface composition and physical state of spray-dried protein powders [J].
Bosquillon, C ;
Rouxhet, PG ;
Ahimou, F ;
Simon, D ;
Culot, C ;
Préat, V ;
Vanbever, R .
JOURNAL OF CONTROLLED RELEASE, 2004, 99 (03) :357-367
[2]   Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols [J].
Chew, NYK ;
Chan, HK .
PHARMACEUTICAL RESEARCH, 1999, 16 (07) :1098-1103
[3]   Effect of amino acids on the dispersion of disodium cromoglycate powders [J].
Chew, NYK ;
Shekunov, BY ;
Tong, HHY ;
Chow, AHL ;
Savage, C ;
Wu, J ;
Chan, HK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (10) :2289-2300
[4]   A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems [J].
Eisenberg, J ;
Pepe, M ;
WilliamsWarren, J ;
Vasiliev, M ;
Montgomery, AB ;
Smith, AL ;
Ramsey, BW ;
Borowitz, D ;
Eigen, H ;
Hiatt, P ;
Moss, R ;
Konstan, M ;
Schidlow, D ;
Wilmott, R ;
Yee, W ;
Crist, D ;
Joy, P ;
McNamara, S ;
Gray, D ;
Pitlick, W .
CHEST, 1997, 111 (04) :955-962
[5]   A multi-institutional outbreak of highly drug-resistant tuberculosis - Epidemiology and clinical outcomes [J].
Frieden, TR ;
Sherman, LF ;
Maw, KL ;
Fujiwara, PI ;
Crawford, JT ;
Nivin, B ;
Sharp, V ;
Hewlett, D ;
Brudney, K ;
Alland, D ;
Kreiswirth, BN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (15) :1229-1235
[6]  
GIRARD PM, 1989, LANCET, V1, P1348
[7]  
HEIFETS L, 2005, M TUBERCULOSIS ANN C, V4, P6
[8]  
Hinds W.C., 1999, Aerosol technology: Properties, behavior, and measurement of airborne particles, V2nd ed., DOI [DOI 10.1016/0021-8502(83)90049-6, 10.1016/0021-8502(83)90049-6]
[9]   A CONTROLLED-STUDY OF INHALED PENTAMIDINE FOR PRIMARY PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA [J].
HIRSCHEL, B ;
LAZZARIN, A ;
CHOPARD, P ;
OPRAVIL, M ;
FURRER, HJ ;
RUTTIMANN, S ;
VERNAZZA, P ;
CHAVE, JP ;
ANCARANI, F ;
GABRIEL, V ;
HEALD, A ;
KING, R ;
MALINVERNI, R ;
MARTIN, JL ;
MERMILLOD, B ;
NICOD, L ;
SIMONI, L ;
VIVIRITO, MC ;
ZERBONI, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (16) :1079-1083
[10]   Practice guidelines for the treatment of tuberculosis [J].
Horsburgh, CR ;
Feldman, S ;
Ridzon, R .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (03) :633-639